Search Results - "Zakharova, T S"

Blood Plasma Lipidome: Opportunities in the Early Diagnostics of Preeclampsia by Torkhovskaya, T. I., Zakharova, T. S., Korotkevich, E. I., Kasum-zade, N. K., Shalina, R. I., Markin, S. S

“…— Blood plasma lipidome analysis is a mass spectrometric (MS) evaluation of molecular types of lipids, sometimes in combination with high performance liquid…”
Get full text

Human Blood Plasma Lipidome: Opportunities and Prospects of Its Analysis in Medical Chemistry by Torkhovskaya, T. I., Zakharova, T. S., Korotkevich, E. I., Ipatova, O. M., Markin, S. S.

“…The emerging development of new analytical mass spectrometry technologies resulted in the possibility of a detailed fractionation of biologically important…”
Get full text

High Density Lipoproteins Phosphatidylcholine as a Regulator of Reverse Cholesterol Transport by Torkhovskaya, T. I., Kudinov, V. A., Zakharova, T. S., Ipatova, O. M., Markin, S. S.

“…Among blood plasma lipoproteins that transport lipids in the organism, a significant role belongs to high-density lipoproteins (HDL). They protect against…”
Get full text

Prednisolone in Phospholipid Nanoparticles: Prolonged Circulation and Increased Antiinflammatory Effect by Prozorovskii, V. N., Ipatova, O. M., Tikhonova, E. G., Zakharova, T. S., Druzhilovskaya, O. S., Korotkevich, E. I., Torkhovskaya, T. I.

“…— Besides application of newly developed pharmacological agents many therapeutic schemes employ known effective drugs, particularly glucocorticoids…”
Get full text

The Increase of Anti-tuberculosis Efficacy of Rifampicin Incorporated Into Phospholipid Nanoparticles with Sodium Oleate by Sanzhakov, M. A., Ipatova, O. M., Torkhovskaya, T. I., Tikhonova, E. G., Medvedeva, N. V., Zakharova, T. S., Prozorovskiy, V. N.

“…— A drug formulation of the anti-tuberculosis drug rifampicin, incorporated in nanoparticles (of 20–30 nm in diameter) from soy phosphatidylcholine with the…”
Get full text

Pharmacological Targets for Correction of Dyslipidemias. Opportunities and Prospects of Therapeutic Use by Kudinov, V. A., Zakharova, T. S., Torkhovskaya, T. I., Ipatova, O. M., Archakov, A. I.

“…The review summarizes literature data on existing pharmacological agents and novel drug preparations developed for correction of dyslipidemias and molecular…”
Get full text

Lysophospholipid receptors in cell signaling by Torkhovskaya, T I, Ipatova, O M, Zakharova, T S, Kochetova, M M, Khalilov, E M

“…There is increasing evidence that different phospholipids are involved in regulation of various cell processes and cell-cell interactions. Lysophospholipids…”
Get full text

The effect of resveratrol and dihydroquercetin inclusion into phospholipid nanopatricles on their bioavalability and specific activity by Guseva, D. A., Khudoklinova, Yu. Yu, Medvedeva, N. V., Baranova, V. S., Zakharova, T. S., Artyushkova, E. B., Torkhovskaya, T. I., Ipatova, O. M.

“…Bioavailability and activity of natural polyphenols, resveratrol (RES) and dihydroquercetin (DHQ), included in phospholipid nanoparticles have been…”
Get full text

Influence of resveratrol and dihydroquercetin inclusion into phospholipid nanopatricles on their bioavailability and specific activity by Guseva, D A, Khudoklinova, Yu Yu, Medvedeva, N V, Baranova, V S, Zakharova, T S, Artyushkova, E B, Torkhovskaya, T I, Ipatova, O M

“…The effects of natural polyphenols, resveratrol (RES) and dihydroquercetin (DHQ), included in phospholipid nanoparticles, have been compared with free…”
Get more information

Influence of doxorubicin inclusion into phospholipid nanoformulation on its antitumor activity in mice: increased efficiency for resistant tumor model by Zykova, M G, Medvedeva, N V, Torkhovskaya, T I, Tikhonova, E G, Prozorovskii, V N, Zakharova, T S, Ipatova, O M

“…The new formulation of doxorubicin on the base of phospholipid nanoparticles (particle size <30 nm) is elaborated in the Institute of Biomedical Chemistry…”
Get more information

The effect of doxorubicin incorporated into a phospholipid delivery nanosystem on HepG2 cells proteome by Kuznetzova, K. G., Kazlas, E. V., Torkhovskaya, T. I., Karalkin, P. A., Vachrushev, I. V., Zakharova, T. S., Sanzhakov, M. A., Moshkovskii, S. A., Ipatova, O. M.

“…A phospholipid drug delivery nanosystem with particle size up to 30 nm elaborated at the Orekhovich Institute of Biomedical Chemistry (Russian Academy of…”
Get full text

Sphingolipids and cell signaling: involvement in apoptosis and atherogenesis by Ipatova, O M, Torkhovskaya, T I, Zakharova, T S, Khalilov, E M

“…This review considers various functional aspects of cell sphingolipids (sphingomyelin, ceramides) and lysosphingolipids (sphingosine-1-phosphate (S1P) and…”
Get full text

Changes of doxorubicin distribution in blood and plasma after its inclusion into nanophospholipid formulations by Zykova, M. G., Ipatova, O. M., Prozorovskii, V. N., Medvedeva, N. V., Voskresenskaya, A. A., Zakharova, T. S., Torkhovskaya, T. I.

“…Using original technology developed at the Institute of Biomedical Chemistry (Russian Academy of Medical Sciences) a drug composition based on plant…”
Get full text

Surface activity of phosphatidylcholines as the basis for surfactant replacement therapy by Zakharova, T. S., Fortinskaya, E. S., Kochetova, M. M., Babakhanov, I. Sh, Torkhovskaya, T. I., Khalilov, E. M.

“…Using the methods of surface balance we compared the effects of different phosphatidylcholines and synthetic surfactant Exosurf on the equilibrium surface…”
Get full text

Comparison of distribution characteristics of phosphatidylcholines and surfactant preparation by Zakharova, T S, Fortinskaya, E S, Kochetova, M M, Torkhovskaya, T I, Khalilov, E M

“…Using the methods of surface balance we compared surface activity of different natural phosphatidylcholines. Dipalmitoylphosphatidylcholine, the principal…”
Get full text

Membrane proteins and phospholipids as effectors of reverse cholesterol transport by Torkhovskaya, T. I., Ipatova, O. M., Medvedeva, N. V., Zakharova, T. S., Khalilov, E. M.

“…The review highlights the membrane aspect of cholesterol efflux from cell membranes to high density lipoproteins (HDL), an initial stage of reverse cholesterol…”
Get full text

Prednisolone in phospholipid nanoparticles: prolonged circulation and increased antiinflammatory effect by Prozorovskii, V N, Ipatova, O M, Tikhonova, E G, Zakharova, T S, Druzhilovskaya, O S, Korotkevich, E I, Torkhovskaya, T I

“…Along with modern new drugs, many therapeutic schemes also include known effective drugs, particularly, glucocorticoids. One of the most distributed of them is…”
Get more information

Pharmacological targets for dislipidemies correction. Opportunities and prospects of therapeutic usage by Kudinov, V A, Zakharova, T S, Torkhovskaya, T I, Ipatova, O M, Archakov, A I

“…Literature data on influence of existing and new groups of drug preparations for dyslipidemias correction are systemized, and molecular mechanisms of their…”
Get more information

Influence of doxorubicin inclusion into phospholipid nanoparticles on tumor accumulation and specific activity by Medvedeva, N V, Torkhovskaya, T I, Kostryukova, L V, Zakharova, T S, Kudinov, V A, Kasatkina, E O, Prozorovskiy, V N, Ipatova, O M

“…The specific activity of drug formulation of doxorubicin embedded into phospholipid nanoparticles with diameter less than 30 nm ("Doxolip") was studied in mice…”
Get more information

The influence of doxorubicin incorporated in phospholipid drug delivery nanosystem on HEPG2 cells proteome by Kuznetzova, K G, Kazlas, E V, Torkhovskaya, T I, Karalkin, P A, Vachrushev, I V, Zakharova, T S, Sanzhakov, M A, Moshkovskiy, S A, Ipatova, O M

“…A phospholipid drug delivery nanosystem with particle size up to 30 nm elaborated at the Institute of Biomedical Chemistry has been used earlier for…”
Get more information